Similar articles for PMID: 19339256

Year	Number of Results
1981	1
1983	1
1986	1
1988	1
1992	3
1993	1
1994	3
1995	1
1996	5
1997	1
1998	1
1999	1
2000	2
2001	6
2002	6
2003	4
2004	3
2005	1
2006	2
2007	3
2008	7
2009	8
2010	8
2011	5
2012	3
2013	8
2014	8
2015	3
2016	2
2017	5
2018	1
2019	1
2020	1
2021	3
2024	0

1

Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis.

Rodgers J, Stone TW, Barrett MP, Bradley B, Kennedy PG. Rodgers J, et al. Brain. 2009 May;132(Pt 5):1259-67. doi: 10.1093/brain/awp074. Epub 2009 Mar 31. Brain. 2009. PMID: 19339256 Free PMC article.

2

Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis.

Rodgers J, Jones A, Gibaud S, Bradley B, McCabe C, Barrett MP, Gettinby G, Kennedy PG. Rodgers J, et al. PLoS Negl Trop Dis. 2011 Sep;5(9):e1308. doi: 10.1371/journal.pntd.0001308. Epub 2011 Sep 6. PLoS Negl Trop Dis. 2011. PMID: 21909447 Free PMC article.

3

Kenyan purple tea anthocyanins and coenzyme-Q10 ameliorate post treatment reactive encephalopathy associated with cerebral human African trypanosomiasis in murine model.

Rashid K, Wachira FN, Nyariki JN, Isaac AO. Rashid K, et al. Parasitol Int. 2014 Apr;63(2):417-26. doi: 10.1016/j.parint.2014.01.001. Epub 2014 Jan 15. Parasitol Int. 2014. PMID: 24440762

4

The continuing problem of human African trypanosomiasis (sleeping sickness).

Kennedy PG. Kennedy PG. Ann Neurol. 2008 Aug;64(2):116-26. doi: 10.1002/ana.21429. Ann Neurol. 2008. PMID: 18756506 Review.

5

Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.

Wenzler T, Yang S, Braissant O, Boykin DW, Brun R, Wang MZ. Wenzler T, et al. Antimicrob Agents Chemother. 2013 Nov;57(11):5330-43. doi: 10.1128/AAC.00398-13. Epub 2013 Aug 19. Antimicrob Agents Chemother. 2013. PMID: 23959303 Free PMC article.

6

[Human African trypanosomiasis].

Dumas M, Bouteille B. Dumas M, et al. C R Seances Soc Biol Fil. 1996;190(4):395-408. C R Seances Soc Biol Fil. 1996. PMID: 8952890 Review. French.

7

Diagnostic and neuropathogenesis issues in human African trypanosomiasis.

Kennedy PG. Kennedy PG. Int J Parasitol. 2006 May 1;36(5):505-12. doi: 10.1016/j.ijpara.2006.01.012. Epub 2006 Mar 3. Int J Parasitol. 2006. PMID: 16546191 Review.

8

Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug.

Sanderson L, da Silva M, Sekhar GN, Brown RC, Burrell-Saward H, Fidanboylu M, Liu B, Dailey LA, Dreiss CA, Lorenz C, Christie M, Persaud SJ, Yardley V, Croft SL, Valero M, Thomas SA. Sanderson L, et al. PLoS Negl Trop Dis. 2021 Apr 15;15(4):e0009276. doi: 10.1371/journal.pntd.0009276. eCollection 2021 Apr. PLoS Negl Trop Dis. 2021. PMID: 33857146 Free PMC article.

9

Chemotherapy of human African trypanosomiasis.

Burchmore RJ, Ogbunude PO, Enanga B, Barrett MP. Burchmore RJ, et al. Curr Pharm Des. 2002;8(4):256-67. doi: 10.2174/1381612023396159. Curr Pharm Des. 2002. PMID: 11860365 Review.

10

Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis.

Kennedy PGE, Rodgers J. Kennedy PGE, et al. Front Immunol. 2019 Jan 25;10:39. doi: 10.3389/fimmu.2019.00039. eCollection 2019. Front Immunol. 2019. PMID: 30740102 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year